Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122407) titled 'A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiation for Newly Diagnosed Limited-Stage Small Cell Lung Cancer' on April 13.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shanghai Pulmonary Hospital
Condition:
limited-stage small cell lung cancer (LS-SCLC)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-20
Target Sample Size: Benmelstobart combined with anlotinib and chemotherapy concurrent with thoracic radiotherapy:27;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=31...